NFKB1 and cancer: The primary mechanism of action of tetrahydroxycurcumin against cancer is through modification of the transcription factors, including inflammatory diseases and cell survival tools, including nuclear factor‐kappa B (NF‐κB) and activator protein‐1 (AP‐1).